CAV2 and head and neck squamous cell carcinoma: We further evaluated the expression of TRIM29 in CAV2-deficient and control HNSCC cells and found that both the mRNA and protein levels of TRIM29 were significantly reduced when CAV2 was silenced (Fig. 6H, I).